ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
TECENTRIQ subkutan 1875 mg/15ml, Injektionslösung zur subkutanen Anwendung - 
69262001 Roche Pharma (Schweiz) AG
TECENTRIQ subkutan 1875 mg/15ml, Injektionslösung zur subkutanen Anwendung05.08.2024
  05.08.2024
(L01FF05) 
WHO-DDD04.08.2029
07.16.10. 
07.16.10. 
A  
Yes 
IP 
4370.35Yes
    
10 %4769.45
  
7680692620019Biotechnologika
  
Composition
atezolizumabum 1875 mg, hyaluronidasum humanum ADNr, histidinum, acidum aceticum 30 per centum, saccharum, polysorbatum 20, methioninum, aqua ad iniectabile ad solutionem pro 15 ml.
Packungsbestandteile
  
  
 
Active AgentDose
 1875mg / 15ml
BAG: Active AgentDose
 1875 mg
 
Inactive agentsDose
Acetic Acid30
Histidine 
  
Methionine 
Per Centum 
  
Saccharum 
 
Source
Data was imported : 05.09.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home